EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dezocine Exerts Analgesic Effects in Chronic Pain by Activation of κ‐ and μ‐Opioid Receptors and Inhibition of Norepinephrine and Serotonin Reuptake

Zihan Liu, Anan Liu, Jing Chen, Jing-Rui Chai, Panwen Liu, Ru-Feng Ye, Jing-Gen Liu iD, Yu-Jun Wang iD

Pain Research and Management · 2025

DOI: 10.1155/prm/5656675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pain Research and Management, 2025. Verfasst von Zihan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China. Hauptthemen laut MEDLINE: Receptors, Opioid, kappa, Receptors, Opioid, mu, Chronic Pain, Tetrahydronaphthalenes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dezocine is a leading analgesic in China used for relieving moderate to severe pain. Previous studies have characterized its pharmacological properties, demonstrating its role as a partial agonist at both the κ‐opioid receptor (KOR) and the μ‐opioid receptor (MOR), thereby producing potent antinociceptive effects in acute pain models. However, its efficacy and mechanisms in chronic pain management remained unclear.

Methods

Chronic pain models, including chronic neuropathic pain and cancer pain, were employed using chronic constriction injury (CCI) of the sciatic nerve and bone cancer pain (BCP) methodologies, respectively. The assessment of the mechanical allodynia was conducted using a von Frey filament.

Results

Dezocine, administered via the intraperitoneal route, alleviated both neuropathic pain and cancer pain in a dose‐dependent manner, with ED 50 of 1.3 mg/kg and 1.6 mg/kg, respectively. In the CCI model, the analgesic effect of dezocine was significantly inhibited by pretreating with KOR antagonist nor‐BNI, MOR antagonist β‐FNA, α2‐adrenoceptor antagonist yohimbine, and 5‐HT2A receptor antagonist altanserin. In the BCP model, dezocine‐induced analgesia was markedly suppressed by nor‐BNI, β‐FNA, and yohimbine but not altanserin.

Conclusion

These results suggest that, in neuropathic pain, the analgesic effects of dezocine are mediated through KOR and MOR activation, together with norepinephrine reuptake inhibition (NRI) and serotonin reuptake inhibition. In contrast, in cancer pain, KOR and MOR activation and NRI are involved in mediating the analgesic effect of dezocine. This study, along with previous data, enhances our understanding of the potential clinical utility of dezocine and elucidates its mechanisms of action in chronic pain management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Opioid, kappaReceptors, Opioid, muChronic PainTetrahydronaphthalenesBridged Bicyclo Compounds, HeterocyclicAnalgesics, OpioidAnalgesicsSerotonin and Noradrenaline Reuptake InhibitorsAnimalsMaleDisease Models, AnimalNeuralgiaRats, Sprague-DawleyRatsMiceHyperalgesiaCancer PainNorepinephrinePain MeasurementDose-Response Relationship, Drug

Stichwörter der Autor:innen

analgesicchronic paindezocinenorepinephrine reuptakeopioid receptorserotonin reuptake

Substanzen

dezocineReceptors, Opioid, kappaReceptors, Opioid, muTetrahydronaphthalenesBridged Bicyclo Compounds, HeterocyclicAnalgesics, OpioidAnalgesicsSerotonin and Noradrenaline Reuptake InhibitorsNorepinephrine

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.
  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.

ORCID-Profile: Jing-Gen Liu, Yu-Jun Wang

Förderung

  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Liu, Z., Liu, A., Chen, J., Chai, J. R., Liu, P., Ye, R. F., Liu, J. G., & Wang, Y. J. (2025). Dezocine Exerts Analgesic Effects in Chronic Pain by Activation of κ‐ and μ‐Opioid Receptors and Inhibition of Norepinephrine and Serotonin Reuptake. Pain Research and Management. https://doi.org/10.1155/prm/5656675

Vancouver

Liu Z, Liu A, Chen J, Chai JR, Liu P, Ye RF, et al. Dezocine Exerts Analgesic Effects in Chronic Pain by Activation of κ‐ and μ‐Opioid Receptors and Inhibition of Norepinephrine and Serotonin Reuptake. Pain Research and Management. 2025. doi:10.1155/prm/5656675

BibTeX
@article{Liu2025,
  author = {Liu, Zihan and Liu, Anan and Chen, Jing and Chai, Jing-Rui and Liu, Panwen and Ye, Ru-Feng and Liu, Jing-Gen and Wang, Yu-Jun},
  title = {Dezocine Exerts Analgesic Effects in Chronic Pain by Activation of κ‐ and μ‐Opioid Receptors and Inhibition of Norepinephrine and Serotonin Reuptake},
  journal = {Pain Research and Management},
  year = {2025},
  doi = {10.1155/prm/5656675}
}
Kostenlos starten →